Endpoints News and Financial Times journalists discuss the downfall of FDA Commissioner Marty Makary, live in New York at the FT's biotech and pharma summit.

Food and Drug Administration Commissioner Marty Makary is resigning from his role after a tumultuous tenure.

Marty Makary, who resigned under pressure from the FDA, brought to the job a fundamental lack of understanding of the nature of the role, STAT's Matthew Herper writes.

What Marty Makary's successor can learn from his mistakes.